Last reviewed · How we verify

NCT03580265

Efficacy of Laser Acupuncture for Carpal Tunnel Syndrome

Status unknown NA Last updated 10 April 2019
What this trial tests

NA trial testing laser phototherapy device with low level laser in Carpal Tunnel Syndrome in 40 participants. Status unknown.

Timeline
1 January 2019
Primary endpoint
31 December 2019
31 December 2019

Quick facts

Lead sponsorTri-Service General Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date1 January 2019
Primary completion31 December 2019
Estimated completion31 December 2019
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Tri-Service General Hospital

Who can join

Adults 20 to 80, any sex, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The laser acupuncture is a new and potential intervention for the disease of peripheral nerve. The purpose of this study was to assess the effect of laser acupucnture therapy on carpal tunnel syndrome.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy of laser acupuncture for carpal tunnel syndrome: A study protocol for a prospective double-blind randomized controlled trial.
    Chen CC, Wu YT, Su YC, Shen YP, et al · · 2019 · cited 7× · PMID 31348263 · DOI 10.1097/md.0000000000016516

Verify or expand the search:

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

Other Tri-Service General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03580265.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing